You just read:

Cellular Biomedicine Group Hosts Meeting with Investigators to Launch AlloJoin® Knee Osteoarthritis Phase II Clinical Trial

News provided by

Cellular Biomedicine Group

Sep 12, 2019, 07:30 ET